🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
NET originate in neuroendocrine cells throughout the body. The goal of this...
Status
Unknown
Location
Oncology Centre, King Faisal Specialist Hospital & Research Center
Start Date
2012-12
Trial ID
NCT03629847
Treatments Being Tested
The purpose of this study is to evaluate the change in the expression of tr...
Status
Active Not Recruiting
Location
Nebraska Cancer Specialists
Start Date
2024-07-29
Trial ID
NCT06379217
The purpose of the study was to evaluate the effect of arginine/lysine solu...
Status
Completed
Location
Istituto Europeo di Oncologia
Start Date
2021-01-25
Trial ID
NCT04524442
Treatments Being Tested
A Dose Finding Study of \[177Lu\]Lu-DOTA-TATE in Newly Diagnosed Glioblasto...
Status
Active Not Recruiting
Location
Col Uni Med Center New York Presby
Start Date
2022-05-10
Trial ID
NCT05109728
Treatments Being Tested
This study will evaluate the safety and efficacy of Lutathera (177Lu-DOTATA...
Status
Recruiting
Location
Children's Hospital Colorado
Start Date
2022-11-21
Trial ID
NCT05278208
Treatments Being Tested
This study was a multicenter observational study with a central registratio...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-12-17
Trial ID
NCT05844332
Treatments Being Tested
An international multi-centre, open, randomised, parallel-group phase II st...
Status
Terminated
Location
Imperial College Healthcare NHS Trust
Start Date
2024-08-02
Trial ID
NCT05987176
Treatments Being Tested
The purpose of this study is to assess the benefit of 177Lu-DOTATATE versus...
Status
Withdrawn
Location
Jules Bordet Institute
Start Date
2014-12
Trial ID
NCT01860742
Treatments Being Tested
This is a prospective, open-label, multi-center, non-comparative, non-inter...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-05-10
Trial ID
NCT04946305
Treatments Being Tested
The LuDO-N Trial is a multi-centre phase II clinical trial on 177Lu-DOTATAT...
Status
Recruiting
Location
Rigshospitalet
Start Date
2021-05-19
Trial ID
NCT04903899
Treatments Being Tested